LPL Financial
CALA

LPL Financial’s Calithera Biosciences, Inc CALA Stock Holding History

LPL Financial’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-873
Closed -$195K – 3001
2017
Q1 		$195K Buy
+873
New +$151K ﹤0.01% 2501
2016
Q2 		– Sell
-641
Closed -$73K – 3067
2016
Q1 		$73K Hold
641
– – ﹤0.01% 2974
2015
Q4 		$100K Buy
+641
New +$96.1K ﹤0.01% 2986

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

LPL Financial's CALA Position: Q2 2017 in Review

LPL Financial sold out of Calithera Biosciences, Inc (CALA) in Q2 2017, closing a stake of 873 shares — an estimated $195K sold.

LPL Financial first reported a position in CALA in Q4 2015 and held it in 3 quarters. The position peaked at $195K in Q1 2017. 94 funds tracked by Wall St. Rank hold CALA as of Q2 2017.

  • LPL Financial reported no remaining Calithera Biosciences, Inc position as of Q2 2017 after selling out during the quarter.
  • LPL Financial sold 873 Calithera Biosciences, Inc shares in Q2 2017, an estimated $195K.
  • LPL Financial first reported a position in Calithera Biosciences, Inc in Q4 2015 and held it in 3 quarters.
  • LPL Financial's Calithera Biosciences, Inc position peaked at $195K in Q1 2017.
  • 94 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2017.

Based on LPL Financial's 13F filing for Q2 2017, filed 14 Aug 2017.